FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists

Source: thehill.com · Section: politics · Bias: Center-Right · Published: Thu, 23 Jul 2026 23:38:26 GMT

On Thursday, the Food and Drug Administration's (FDA) committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits. The FDA's Pharmacy Compounding Advisory Committee (PCAC) heard public comments and saw presentations by agency staffers concerning the peptides BPC-157, KPV, TB-500 and MOTS-c. These...

Read the full article at thehill.com →

The same story across the political spectrum (10 sources)

Left: Red states call out the Trump Administration for its foul food-stamp program — www.rawstory.com
Left: 'Read the room': Trump skewered after telling everyone to stop resisting 'unpopular' issue — www.rawstory.com
Center-Left: US health panel recommends easing restrictions on controversial peptides — www.theguardian.com
Center: Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next. — www.marketwatch.com
Center-Left: Senate preparing to vote on Russia sanctions next week — www.axios.com
Center-Left: FDA Panel Supports Lifting Restrictions on Four Peptides — www.nytimes.com

← Back to FlashTopics.com